June 25, 2022

Brain cancer patient treated with off-label drug frets over costs when insurance coverage stops in April 2023

By brit

SINGAPORE – Mr Zhang Chang Hua is 42 years old and works in regional customer service for a multinational company. He and his wife, a nurse, have two sons in secondary school. He also has brain cancer.

His cancer has been under control for the past year with a drug used off-label – meaning the drug has not been approved for this particular type of cancer. With this drug, his oncologist says he has many good years ahead of him.